Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Causality assessment methods in drug induced liver injury: strengths and weaknesses.
García-Cortés M, Stephens C, Lucena MI, Fernández-Castañer A, Andrade RJ; Spanish Group for the Study of Drug-Induced Liver Disease (Grupo de Estudio para las Hepatopatías Asociadas a Medicamentos GEHAM).
J Hepatol. 2011 Sep;55(3):683-91. Epub 2011 Feb 22. Review.
Related citations
Gamma-glutamyltransferase, general and cause-specific mortality in 19,000 construction workers followed over 20 years.
Breitling LP, Claessen H, Drath C, Arndt V, Brenner H.
J Hepatol. 2011 Sep;55(3):594-601. Epub 2011 Jan 21.
Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver.
Begriche K, Massart J, Robin MA, Borgne-Sanchez A, Fromenty B.
J Hepatol. 2011 Apr;54(4):773-94. Epub 2010 Nov 17. Review.
Drug induced liver injury and its relationship to autoimmune hepatitis.
Weiler-Normann C, Schramm C.
J Hepatol. 2011 Oct;55(4):747-9. Epub 2011 Mar 9. No abstract available.
The protective role of hydrogen-rich saline in experimental liver injury in mice.
Sun H, Chen L, Zhou W, Hu L, Li L, Tu Q, Chang Y, Liu Q, Sun X, Wu M, Wang H.
J Hepatol. 2011 Mar;54(3):471-80. Epub 2010 Sep 25.
Recurrent drug-induced liver injury (DILI) with different drugs in the Spanish Registry: the dilemma of the relationship to autoimmune hepatitis.
Lucena MI, Kaplowitz N, Hallal H, Castiella A, García-Bengoechea M, Otazua P, Berenguer M, Fernandez MC, Planas R, Andrade RJ.
J Hepatol. 2011 Oct;55(4):820-7. Epub 2011 Feb 19.
Insufficient bile acid signaling impairs liver repair in CYP27(-/-) mice.
Meng Z, Liu N, Fu X, Wang X, Wang YD, Chen WD, Zhang L, Forman BM, Huang W.
J Hepatol. 2011 Oct;55(4):885-95. Epub 2011 Feb 18.
Treatment of murine fulminant hepatitis with genetically engineered endothelial progenitor cells.
Fernandez-Ruiz V, Kawa M, Berasain C, Iñiguez M, Schmitz V, Martinez-Ansó E, Iñarrairaegui M, Herrero I, Sangro B, D'Avola D, Quiroga J, Qian C, Prieto J.
J Hepatol. 2011 Oct;55(4):828-37. Epub 2011 Feb 18.
Drug-induced liver injury: is it time for genetics to change our clinical practice?
Invernizzi P.
J Hepatol. 2010 Dec;53(6):993-4. Epub 2010 Aug 19. No abstract available.
Human leucocyte antigen class II genotype in susceptibility and resistance to co-amoxiclav-induced liver injury.
Donaldson PT, Daly AK, Henderson J, Graham J, Pirmohamed M, Bernal W, Day CP, Aithal GP.
J Hepatol. 2010 Dec;53(6):1049-53. Epub 2010 Aug 1.
CD1d-restricted natural killer T cells contribute to hepatic inflammation and fibrogenesis in mice.
Ishikawa S, Ikejima K, Yamagata H, Aoyama T, Kon K, Arai K, Takeda K, Watanabe S.
J Hepatol. 2011 Jun;54(6):1195-204. Epub 2010 Nov 5.
The synthetic bile acid-phospholipid conjugate ursodeoxycholyl lysophosphatidylethanolamide suppresses TNFα-induced liver injury.
Pathil A, Warth A, Chamulitrat W, Stremmel W.
J Hepatol. 2011 Apr;54(4):674-84. Epub 2010 Sep 27.
Tempol administration, a superoxide dismutase mimetic, reduces hepatic vascular resistance and portal pressure in cirrhotic rats.
García-Calderó H, Rodríguez-Vilarrupla A, Gracia-Sancho J, Diví M, Laviña B, Bosch J, García-Pagán JC.
J Hepatol. 2011 Apr;54(4):660-5. Epub 2010 Sep 25.
Preservation of basal AcSDKP attenuates carbon tetrachloride-induced fibrosis in the rat liver.
Chen YW, Liu BW, Zhang YJ, Chen YW, Dong GF, Ding XD, Xu LM, Pat B, Fan JG, Li DG.
J Hepatol. 2010 Sep;53(3):528-36. Epub 2010 May 31.
The NF-kappaB p50:p50:HDAC-1 repressor complex orchestrates transcriptional inhibition of multiple pro-inflammatory genes.
Elsharkawy AM, Oakley F, Lin F, Packham G, Mann DA, Mann J.
J Hepatol. 2010 Sep;53(3):519-27. Epub 2010 Jun 2.
Soluble TNF, but not membrane TNF, is critical in LPS-induced hepatitis.
Olleros ML, Vesin D, Fotio AL, Santiago-Raber ML, Tauzin S, Szymkowski DE, Garcia I.
J Hepatol. 2010 Dec;53(6):1059-68. Epub 2010 Aug 4.
Near-infrared confocal imaging during mini-laparoscopy: a novel rigid endomicroscope with increased imaging plane depth.
Goetz M, Deris I, Vieth M, Murr E, Hoffman A, Delaney P, Galle PR, Neurath MF, Kiesslich R.
J Hepatol. 2010 Jul;53(1):84-90. Epub 2010 Apr 8.
Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinoma.
Hsu CH, Shen YC, Lin ZZ, Chen PJ, Shao YY, Ding YH, Hsu C, Cheng AL.
J Hepatol. 2010 Jul;53(1):126-31. Epub 2010 Mar 30.
TGF-beta enhances alcohol dependent hepatocyte damage via down-regulation of alcohol dehydrogenase I.
Ciuclan L, Ehnert S, Ilkavets I, Weng HL, Gaitantzi H, Tsukamoto H, Ueberham E, Meindl-Beinker NM, Singer MV, Breitkopf K, Dooley S.
J Hepatol. 2010 Mar;52(3):407-16. Epub 2010 Jan 6.
Resolution of inflammation-related apoptotic processes by the synthetic tellurium compound, AS101 following liver injury.
Brodsky M, Hirsh S, Albeck M, Sredni B.
J Hepatol. 2009 Sep;51(3):491-503. Epub 2009 Jun 6.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on